Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration
Catia Marzolini, Serge Leyvraz(Humboldt-Universität zu Berlin), Jean Bauer(European Institute of Oncology), J Biollaz(Centre Hospitalier Universitaire Vaudois), Thierry Buclin(Hôpital de Beaumont), Fei Shen(Changchun University of Science and Technology), Laurent A. Décosterd(University of Lausanne), Marc Gander(Centre Hospitalier Universitaire Vaudois), Ferdy J. Lejeune
Cited by 68
Related Papers
Isolated Limb Perfusion with Tumor Necrosis Factor and Melphalan for Limb Salvage in 186 Patients with Locally Advanced Soft Tissue Extremity Sarcomas
|Annals of Surgery|1996|458
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.
|Journal of Clinical Oncology|1996|401
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
|EMBO Molecular Medicine|2014|388
The effect of economic growth target constraints on green technology innovation
|Journal of Environmental Management|2021|347